Efficacy of PARP Inhibitors, Bevacizumab and Platinum Based Chemotherapy in Treatment Regimen of Patients with BRCA1/2-mutated Ovarian Cancer
PDF

How to Cite

1.
Mahnoor Junaid Malik, Salman Jameel Malik. Efficacy of PARP Inhibitors, Bevacizumab and Platinum Based Chemotherapy in Treatment Regimen of Patients with BRCA1/2-mutated Ovarian Cancer. sjrmu [Internet]. 2025 Jun. 13 [cited 2025 Dec. 29];28(02):129-32. Available from: https://supp.journalrmc.com.135-181-231-204.cpanel.site/index.php/public/article/view/350